Innate Pharma to present IPH4102 “TELLOMAK” clinical trial design and preclinical PTCL data at the 2019 ICML

    NEXT STORY
    Global Genetic Testing Markets, 2019-2023 – New Knowledge, Combined with Lower Pricing is Driving the Market
    PREV STORY
    Helsinn to co-support a satellite symposium on current and emerging treatments of Acute Myeloid Leukemia (AML) at 24th European Hematology Association (EHA) Congress
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Cue Biopharma to Host Investor Business Update Call and Webcast

    Update on progress of selective immune modulation platformCAMBRIDGE, Mass., May 10, 2018 (GLOBE NEWSWIRE) ...

    author_avatar
    NASDAQ Market News

    BeiGene Announces Approval of REVLIMID® for Newly Diagnosed Multiple Myeloma in China

    BEIJING, China, and CAMBRIDGE, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), ...

    author_avatar
    NASDAQ Market News

    Nitinol Medical Devices Market to reach US$25,657.5 mn by 2025 – Transparency Market Research

    Albany - NY, Nov. 10, 2017 (GLOBE NEWSWIRE) -- Transparency Market Research has published ...

    author_avatar
    NASDAQ Market News